Kreitman, R. J. (2018). Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: Phase 1 results and long-term follow-up. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationKreitman, R. J. Minimal Residual Hairy Cell Leukemia Eradication with Moxetumomab Pasudotox: Phase 1 Results and Long-term Follow-up. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationKreitman, R. J. Minimal Residual Hairy Cell Leukemia Eradication with Moxetumomab Pasudotox: Phase 1 Results and Long-term Follow-up. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.